• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Causes of renal allograft loss. Progress in the 1980s, challenges for the 1990s.肾移植失败的原因。20世纪80年代的进展,20世纪90年代的挑战。
Ann Surg. 1991 Dec;214(6):679-88. doi: 10.1097/00000658-199112000-00007.
2
The UNOS Scientific Renal Transplant Registry.美国器官共享联合网络科学肾脏移植登记处。
Clin Transpl. 1999:1-21.
3
The UNOS renal transplant registry.美国器官共享联合网络肾脏移植登记处。
Clin Transpl. 2001:1-18.
4
Kidney transplantation, the Halifax experience.肾移植:哈利法克斯的经验
Clin Transpl. 1996:231-40.
5
The LifeLink Foundation and cadaver kidney transplantation in Tampa.生命链接基金会与坦帕的尸体肾移植
Clin Transpl. 1999:149-58.
6
2,500 living donor kidney transplants: a single-center experience.2500例活体供肾肾移植:单中心经验
Ann Surg. 2001 Aug;234(2):149-64. doi: 10.1097/00000658-200108000-00004.
7
Renal transplantation at the University of Pennsylvania Medical Center: an update of results in the cyclosporine era.宾夕法尼亚大学医学中心的肾移植:环孢素时代的结果更新
Clin Transpl. 1992:215-25.
8
The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants.美国器官共享联合网络科学肾脏移植登记处——十年肾脏移植情况
Clin Transpl. 1997:1-14.
9
Annual trends and triple therapy--1991-2000.1991 - 2000年的年度趋势与三联疗法
Clin Transpl. 2001:247-69.
10
[Delayed graft function and its impact on the antigraft response after cadaver kidney transplantation].[尸体肾移植术后移植肾功能延迟及其对抗移植反应的影响]
Medicina (Kaunas). 2005;41 Suppl 1:101-6.

引用本文的文献

1
Human kidney graft survival correlates with structural parameters in baseline biopsies: a quantitative observational cohort study with more than 14 years' follow-up.人肾移植存活率与基线活检的结构参数相关:一项超过14年随访的定量观察性队列研究。
Virchows Arch. 2021 Apr;478(4):659-668. doi: 10.1007/s00428-020-02924-3. Epub 2020 Sep 28.
2
The risk factors associated with treatment-related mortality in 16,073 kidney transplantation-A nationwide cohort study.与 16073 例肾移植治疗相关死亡率相关的危险因素:一项全国性队列研究。
PLoS One. 2020 Jul 28;15(7):e0236274. doi: 10.1371/journal.pone.0236274. eCollection 2020.
3
Biological pathways and potential targets for prevention and therapy of chronic allograft nephropathy.慢性移植肾肾病预防与治疗的生物学途径及潜在靶点
Biomed Res Int. 2014;2014:482438. doi: 10.1155/2014/482438. Epub 2014 May 27.
4
Causes of death in renal transplant recipients with functioning allograft.移植肾有功能的肾移植受者的死亡原因
Indian J Nephrol. 2012 Jul;22(4):264-8. doi: 10.4103/0971-4065.101245.
5
Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection.肾移植中的免疫抑制药物:对患者生存率、心血管疾病、恶性肿瘤及感染发生率的影响
Drugs. 2009 Nov 12;69(16):2227-43. doi: 10.2165/11319260-000000000-00000.
6
Everolimus: a review of its use in renal and cardiac transplantation.依维莫司:其在肾移植和心脏移植中应用的综述
Drugs. 2006;66(4):547-70. doi: 10.2165/00003495-200666040-00009.
7
Chronic allograft nephropathy and mycophenolate mofetil introduction in paediatric renal recipients.儿科肾移植受者中的慢性移植肾肾病及霉酚酸酯的应用
Pediatr Nephrol. 2005 Nov;20(11):1630-5. doi: 10.1007/s00467-005-2012-8. Epub 2005 Aug 16.
8
Combating chronic renal allograft dysfunction : optimal immunosuppressive regimens.对抗慢性肾移植功能障碍:最佳免疫抑制方案
Drugs. 2005;65(5):615-31. doi: 10.2165/00003495-200565050-00004.
9
The effect of different immunosuppressants on alloantigen dependent and independent factors involved in the development of chronic rejection in an animal model.在动物模型中,不同免疫抑制剂对参与慢性排斥反应发生的同种异体抗原依赖性和非依赖性因素的影响。
Ann R Coll Surg Engl. 2001 Jul;83(4):235-43.
10
Decreased acute rejection in kidney transplant recipients is associated with decreased chronic rejection.肾移植受者急性排斥反应的降低与慢性排斥反应的降低相关。
Ann Surg. 1999 Oct;230(4):493-8; discussion 498-500. doi: 10.1097/00000658-199910000-00005.

本文引用的文献

1
A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES.一种用于比较任意单删失样本的广义威尔科克森检验。
Biometrika. 1965 Jun;52:203-23.
2
REJECTION OF KIDNEY HOMOTRANSPLANTS.同种异体肾移植的排斥反应
Ann N Y Acad Sci. 1964 Nov 30;120:472-95. doi: 10.1111/j.1749-6632.1964.tb34746.x.
3
Compensatory renal hemodynamic injury: a final common pathway of residual nephron destruction.代偿性肾血流动力学损伤:残余肾单位破坏的最终共同途径。
Am J Kidney Dis. 1982 Mar;1(5):310-4. doi: 10.1016/s0272-6386(82)80032-2.
4
Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease.膳食蛋白质摄入量与肾脏疾病的进展特性:血流动力学介导的肾小球损伤在衰老、肾切除及原发性肾脏疾病所致进行性肾小球硬化发病机制中的作用
N Engl J Med. 1982 Sep 9;307(11):652-9. doi: 10.1056/NEJM198209093071104.
5
The improving utility of renal transplantation in the management of end-stage renal disease.肾移植在终末期肾病治疗中的效用不断提高。
Am J Med. 1982 Jul;73(1):105-24. doi: 10.1016/0002-9343(82)90937-8.
6
Late mortality and morbidity in recipients of long-term renal allografts.长期肾移植受者的晚期死亡率和发病率
Transplantation. 1982 Dec;34(6):347-51. doi: 10.1097/00007890-198212000-00007.
7
Long-term results of renal transplantation in recipients with a functioning graft for 2 years.移植肾有功能2年的受者肾移植长期结果。
Transplantation. 1982 Nov;34(5):264-7. doi: 10.1097/00007890-198211000-00005.
8
Fractionated total lymphoid irradiation as preparative immunosuppression in high risk renal transplantation: clinical and immunological studies.分次全身淋巴组织照射作为高危肾移植的预处理免疫抑制:临床与免疫学研究
Ann Surg. 1982 Oct;196(4):442-52. doi: 10.1097/00000658-198210000-00007.
9
An analysis of the United States renal transplant patient population and organ survival characteristics: 1977 to 1980.1977年至1980年美国肾移植患者群体及器官存活特征分析
Kidney Int. 1982 Dec;22(6):685-92. doi: 10.1038/ki.1982.230.
10
Interleukin 1, a potential regulator of fibroblast proliferation.白细胞介素1,一种成纤维细胞增殖的潜在调节因子。
J Immunol. 1982 May;128(5):2177-82.

肾移植失败的原因。20世纪80年代的进展,20世纪90年代的挑战。

Causes of renal allograft loss. Progress in the 1980s, challenges for the 1990s.

作者信息

Schweitzer E J, Matas A J, Gillingham K J, Payne W D, Gores P F, Dunn D L, Sutherland D E, Najarian J S

机构信息

Department of Surgery, University of Minnesota, Minneapolis.

出版信息

Ann Surg. 1991 Dec;214(6):679-88. doi: 10.1097/00000658-199112000-00007.

DOI:10.1097/00000658-199112000-00007
PMID:1741647
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1358492/
Abstract

A variety of refinements in the care of kidney transplant recipients have been instituted over the past decade. The authors studied the overall impact of these refinements on kidney allograft losses at a single institution. To do this they compared the causes and rates of graft loss for primary kidney transplants in the 1970s (January 1, 1970 to December 31, 1979; n = 1012; 657 nondiabetics, 355 diabetics; 617 living donors, 395 cadaver donors) versus the 1980s (January 1, 1980 to December 31, 1989; n = 1,384; 756 nondiabetics, 628 diabetics; 740 living donors, 644 cadaver donors). Overall patient survival improved significantly, with rates at 1, 5, and 10 years of 94%, 84%, and 68% for the 1980s, compared with 86%, 69%, and 57% for the 1970s (p less than 0.001). Actuarial graft survival also improved significantly, with rates at 1, 5, and 10 years of 86%, 71%, and 52% for the 1980s, compared with 73%, 58%, and 43% for the 1970s (p less than 0.001). This improvement occurred even though there were proportionately more cadaver donors and diabetic recipients in the 1980s. For both decades combined, 24% of the lost grafts were due to chronic rejection, 18% to cardiovascular causes of death with function, 13% to infectious causes of death with function, and 11% to acute rejection. The overall gain in graft survival rates in the 1980s was principally due to fewer cases of acute rejection and fewer infectious deaths. Improvement in graft survival due to the two leading causes--chronic rejection and cardiovascular causes of death--was relatively small, if any. These data indicate that future kidney transplantation research should emphasize prevention of chronic rejection and cardiovascular death.

摘要

在过去十年中,针对肾移植受者的护理采取了多种改进措施。作者在单一机构研究了这些改进措施对肾移植失败的总体影响。为此,他们比较了20世纪70年代(1970年1月1日至1979年12月31日;n = 1012;657名非糖尿病患者,355名糖尿病患者;617名活体供者,395名尸体供者)与20世纪80年代(1980年1月1日至1989年12月31日;n = 1384;756名非糖尿病患者,628名糖尿病患者;740名活体供者,644名尸体供者)原发性肾移植的移植失败原因和发生率。总体患者生存率显著提高,20世纪80年代1年、5年和10年的生存率分别为94%、84%和68%,而20世纪70年代分别为86%、69%和57%(p<0.001)。移植精算生存率也显著提高,20世纪80年代1年、5年和10年的生存率分别为86%、71%和52%,而20世纪70年代分别为73%、58%和43%(p<0.001)。尽管20世纪80年代尸体供者和糖尿病受者的比例相对较高,但仍有这样的改善。在这两个十年中,24%的移植失败是由于慢性排斥反应,18%是由于伴有功能的心血管死亡原因,13%是由于伴有功能的感染性死亡原因,11%是由于急性排斥反应。20世纪80年代移植生存率的总体提高主要是由于急性排斥反应病例减少和感染性死亡减少。由两个主要原因——慢性排斥反应和心血管死亡原因——导致的移植生存率的提高(如果有的话)相对较小。这些数据表明,未来肾移植研究应强调预防慢性排斥反应和心血管死亡。